TherVoyant: Enabling an Entirely New Field of Medicine
TherVoyant has actively pursued the aim of becoming the industry leader in the radiology/MRI diagnostics market. A combination of a strong scientific and executive leadership team has enabled the company to develop revolutionary software applications to meet the expanding need in the areas of neurosurgery, oncology and new drug therapies.
In 2012, researchers at UW-Madison recognized a clinical need for immediate surgical feedback using Real-Time MRI. In 2015, InseRT-MRI (now TherVoyant) was formed as a small business with strong expertise in MRI imaging and neurosurgery.
Thervoyant has a Patent-Pending on the GuideRT platform and is on track to commercialize its suite of products.
TherVoyant provides a solution where everyone wins- the patient, the surgeon, the hospital and the scanner manufacturer. Real-Time MRI opens the door to a host of new procedures which can provide new options to treat difficult diseases.
If you are interested in learning more about TherVoyant, or for financial or investment inquiries, please Contact Us.